The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis

by Merle I. Ronden, MD, Idris Bahce, MD, PhD, Niels J.M. Claessens, MD, Nicole Barlo, MD, Max R. Dahele, MD, PhD, Johannes M.A. Daniels, MD, PhD, Caroline Tissing-Tan, MD, Edo Hekma, MD, Sayed M.S. Hashemi, MD, Antoinet van der Wel, MD, Femke O.B. Spoelstra, MD, PhD, Wilko F.A. R. Verbakel, MD, PhD, Marian A. Tiemessen, MD, Marjolein van Laren, MD, Annemarie Becker, MD, PhD, Svitlana Tarasevych, MD, Cornelis J.A. Haasbeek, MD, PhD, Karen Maassen van den Brink, MD, Chris Dickhoff, MD, PhD, Suresh Senan, MRCP, FRCR, PhD
Published 2021-07-01